BCB
Brian C. Broderick Portfolio holdings
AUM
$506M
This Quarter Return
+10.71%
1 Year Return
+12.39%
3 Year Return
+70.69%
5 Year Return
+110.99%
10 Year Return
+270.67%
AUM
$416M
AUM Growth
+$416M
(+11%)
Cap. Flow
+$4.95M
Cap. Flow
% of AUM
1.19%
Top 10 Holdings %
Top 10 Hldgs %
39.12%
Holding
82
New
2
Increased
36
Reduced
23
Closed
8
Top Buys
| 1 |
Edwards Lifesciences
EW
|
$1.9M |
| 2 |
Aptiv
APTV
|
$1.33M |
| 3 |
Nike
NKE
|
$1.24M |
| 4 |
TJX Companies
TJX
|
$1.08M |
| 5 |
Amazon
AMZN
|
$964K |
Top Sells
| 1 |
Novartis
NVS
|
$2.39M |
| 2 |
Chubb
CB
|
$1.94M |
| 3 |
Cisco
CSCO
|
$921K |
| 4 |
Intel
INTC
|
$864K |
| 5 |
Danaher
DHR
|
$697K |
Sector Composition
| 1 | Healthcare | 21.79% |
| 2 | Technology | 21.05% |
| 3 | Industrials | 12.84% |
| 4 | Consumer Discretionary | 8.39% |
| 5 | Communication Services | 6.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
CVS Health
CVS
$93B
| $6.24M | 1.5% |
60,478
+775
| +1% | +$80K |
|
|
27
Nike
NKE
$110B
| $5.84M | 1.4% |
35,006
+7,445
| +27% | +$1.24M |
|
28
Illumina
ILMN
$15.2B
| $5.69M | 1.37% |
14,955
+1,145
| +8% | +$436K |
|
29
Unilever
UL
$158B
| $5.24M | 1.26% |
97,459
-480
| -0.5% | -$25.8K |
|
30
Becton Dickinson
BDX
$54.3B
| $5.14M | 1.24% |
20,456
-785
| -4% | -$197K |
|
31
PepsiCo
PEP
$203B
| $4.18M | 1.01% |
24,068
+895
| +4% | +$155K |
|
|
32
Novartis
NVS
$248B
| $3.6M | 0.86% |
41,100
-27,295
| -40% | -$2.39M |
|
|
33
Edwards Lifesciences
EW
$47.7B
| $3.55M | 0.85% |
27,417
+14,698
| +116% | +$1.9M |
|
34
Chevron
CVX
$318B
| $3.23M | 0.78% |
27,491
+300
| +1% | +$35.2K |
|
35
Exxon Mobil
XOM
$477B
| $2.22M | 0.53% |
36,304
-7,050
| -16% | -$431K |
|
36
AbbVie
ABBV
$374B
| $2.15M | 0.52% |
15,902
-10
| -0.1% | -$1.35K |
|
37
SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$11B
| $1.96M | 0.47% |
33,600
-1,500
| -4% | -$87.7K |
|
38
Church & Dwight Co
CHD
$22.7B
| $1.84M | 0.44% |
17,988
+6,500
| +57% | +$666K |
|
39
3M
MMM
$81B
| $1.82M | 0.44% |
10,220
-3,425
| -25% | -$609K |
|
|
40
Aptiv
APTV
$17.3B
| $1.76M | 0.42% |
10,662
+8,044
| +307% | +$1.33M |
|
|
41
Intel
INTC
$105B
| $1.75M | 0.42% |
33,955
-16,775
| -33% | -$864K |
|
42
Ironwood Pharmaceuticals
IRWD
$201M
| $1.2M | 0.29% |
102,946
-38,404
| -27% | -$448K |
|
43
Welltower
WELL
$112B
| $850K | 0.2% |
9,910
| – | – |
|
44
Trane Technologies
TT
$90.9B
| $802K | 0.19% |
3,970
-100
| -2% | -$20.2K |
|
45
Bristol-Myers Squibb
BMY
$96.7B
| $729K | 0.18% |
11,700
| – | – |
|
46
Thermo Fisher Scientific
TMO
$183B
| $717K | 0.17% |
1,075
-10
| -0.9% | -$6.67K |
|
47
Union Pacific
UNP
$132B
| $707K | 0.17% |
2,809
-880
| -24% | -$221K |
|
48
Pembina Pipeline
PBA
$21.9B
| $680K | 0.16% |
22,428
| – | – |
|
49
Novo Nordisk
NVO
$252B
| $558K | 0.13% |
4,985
+910
| +22% | +$102K |
|
|
50
Cisco
CSCO
$268B
| $551K | 0.13% |
8,685
-14,520
| -63% | -$921K |
|